Showing 1 - 7 results of 7 for search 'Mohamed A. Yassin (16322749)', query time: 0.01s Refine Results
  1. 1
    A study of <sup>18</sup>F-FLT positron emission tomography/computed tomography imaging in pediatrics with myeloproliferative neoplasms

    A study of <sup>18</sup>F-FLT positron emission tomography/computed tomography imaging in pediatrics with myeloproliferative neoplasms by Mohamed A. Yassin (16322749)

    Published 2021
    Save to List
    Saved in:
  2. 2
    Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis

    Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis by Mohamed A. Yassin (16322749)

    Published 2020
    Save to List
    Saved in:
  3. 3
    Dasatinib versus nilotinib as upfront therapy for treatment naïve chronic myeloid leukemia chronic phase

    Dasatinib versus nilotinib as upfront therapy for treatment naïve chronic myeloid leukemia chronic phase by Mohamed A. Yassin (16322749)

    Published 2021
    Save to List
    Saved in:
  4. 4
    A study of 18F-FLT positron emission tomography/computed tomography imaging in cases of prefibrotic/early primary myelofibrosis and essential thrombocythemia

    A study of 18F-FLT positron emission tomography/computed tomography imaging in cases of prefibrotic/early primary myelofibrosis and essential thrombocythemia by Mohamed A. Yassin (16322749)

    Published 2020
    Save to List
    Saved in:
  5. 5
    Rebound of platelet count in a patient with type 2 calreticulin-mutant essential thrombocythemia in the postpartum period  A case report

    Rebound of platelet count in a patient with type 2 calreticulin-mutant essential thrombocythemia in the postpartum period  A case report by Abdulrahman F. Al-Mashdali (16322744)

    Published 2021
    Other Authors: “…Mohamed A. Yassin (16322749)…”
    Save to List
    Saved in:
  6. 6
    Ruxolitinib (a JAK2 inhibitor) as an emerging therapy for refractory pruritis in a patient with low-risk polycythemia vera A case report

    Ruxolitinib (a JAK2 inhibitor) as an emerging therapy for refractory pruritis in a patient with low-risk polycythemia vera A case report by Abdulrahman F. Al-Mashdali (16322744)

    Published 2021
    Other Authors:
    Save to List
    Saved in:
  7. 7
    Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents A protocol for systematic review and meta-analysis

    Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents A protocol for systematic review and meta-analysis by Nancy Kassem (3517106)

    Published 2020
    Other Authors:
    Save to List
    Saved in:

Search Tools: